Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HDAC11 suppresses the thermogenic program of adipose tissue via BRD2
Rushita A. Bagchi, Bradley S. Ferguson, Matthew S. Stratton, Tianjing Hu, Maria A. Cavasin, Lei Sun, Ying-Hsi Lin, Dianxin Liu, Pilar Londono, Kunhua Song, Maria F. Pino, Lauren M. Sparks, Steven R. Smith, Philipp E. Scherer, Sheila Collins, Edward Seto, Timothy A. McKinsey
Rushita A. Bagchi, Bradley S. Ferguson, Matthew S. Stratton, Tianjing Hu, Maria A. Cavasin, Lei Sun, Ying-Hsi Lin, Dianxin Liu, Pilar Londono, Kunhua Song, Maria F. Pino, Lauren M. Sparks, Steven R. Smith, Philipp E. Scherer, Sheila Collins, Edward Seto, Timothy A. McKinsey
View: Text | PDF
Research Article Metabolism

HDAC11 suppresses the thermogenic program of adipose tissue via BRD2

  • Text
  • PDF
Abstract

Little is known about the biological function of histone deacetylase 11 (HDAC11), which is the lone class IV HDAC. Here, we demonstrate that deletion of HDAC11 in mice stimulates brown adipose tissue (BAT) formation and beiging of white adipose tissue (WAT). Consequently, HDAC11-deficient mice exhibit enhanced thermogenic potential and, in response to high-fat feeding, attenuated obesity, improved insulin sensitivity, and reduced hepatic steatosis. Ex vivo and cell-based assays revealed that HDAC11 catalytic activity suppresses the BAT transcriptional program, in both the basal state and in response to β-adrenergic receptor signaling, through a mechanism that is dependent on physical association with BRD2, a bromodomain and extraterminal (BET) acetyl-histone-binding protein. These findings define an epigenetic pathway for the regulation of energy homeostasis and suggest the potential for HDAC11-selective inhibitors for the treatment of obesity and diabetes.

Authors

Rushita A. Bagchi, Bradley S. Ferguson, Matthew S. Stratton, Tianjing Hu, Maria A. Cavasin, Lei Sun, Ying-Hsi Lin, Dianxin Liu, Pilar Londono, Kunhua Song, Maria F. Pino, Lauren M. Sparks, Steven R. Smith, Philipp E. Scherer, Sheila Collins, Edward Seto, Timothy A. McKinsey

×

Figure 5

HDAC11 knockdown enhances differentiation of MEFs into brown adipocyte–like cells.

Options: View larger image (or click on image) Download as PowerPoint
HDAC11 knockdown enhances differentiation of MEFs into brown adipocyte–l...
(A) Schematic representation of the MEF differentiation (Diff) assay. (B) Phase-contrast images of MEFs differentiated into brown adipocyte–like cells. BODIPY staining shows multilocular lipid droplets characteristic of brown adipocytes. Scale bars: 100 μm. (C) Lipid content was quantified using colorimetric oil red O staining; n = 4 plates/condition. (D and E) qPCR analysis of Hdac11 and Ucp1 mRNA expression; n = 4 plates of cells/condition. (F) Immunoblot analysis of UCP1 and PGC1α protein expression; each lane represents protein from an independent plate of cells. Calnexin served as a loading control. (G) qPCR analysis of Pgc1α mRNA expression; n = 4 plates of cells/condition. (H) Schematic representation of the β3-AR signaling assay. (I) qPCR analysis of Ucp1 mRNA expression following 2 hours of treatment of cells with CL-316,243 or vehicle control; n = 4 plates of cells/condition. Values for all graphs represent mean ± SEM; *P < 0.05 vs. shControl undifferentiated or unstimulated; #P < 0.05 vs. shControl differentiated or stimulated using ANOVA with Tukey’s multiple-comparisons test. †P < 0.05 vs. shControl differentiated or stimulated; ‡P < 0.05 vs. shControl undifferentiated or unstimulated using Student’s t test following significant ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts